What they were paid
Humacyte Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $50,000 | $0 | $152,800 | $0 | $202,800 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Humacyte, Inc. DEF 14A filed April 28, 2026, accession 0001193125-26-187449, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Humacyte pays directors a $50,000 cash retainer and $152,800 in equity.
Committees
FY2025 · as the proxy prints themCommercial
The rest of the Humacyte board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Brady W. Dougan | Director | $202,800 |
| C. Bruce Green | Independent Director | $202,800 |
| Emery N. Brown | Independent Director | $202,800 |
| John P. Bamforth | Independent Director | $202,800 |
| Kathleen Sebelius | Chair of the Board | $227,800 |
| Keith Anthony Jones | Independent Director | $202,800 |
| Laura E. Niklason | Director | $0 |
| Max Wallace | Independent Director | $207,800 |
| Michael T. Constantino | Independent Director | $210,300 |
| Susan Windham-Bannister | Independent Director | $207,800 |
| Todd M. Pope | Independent Director | $207,800 |
The full Humacyte compensation record
free company briefThis page is one director within Humacyte's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat